SARS-CoV-2 Infection in Pregnant Women and Their Newborns.
Melanie EttiMusa SekikuboVictoria NankabirwaHalvor SommerfeltBridget FreyneKondwani KawazaGladys GadamaKondwani JamboEsperança SeveneMarleen TemmermanLaura A MageePeter von DadelszenAsma KhalilKirsty Le Doarenull nullPublished in: Annals of global health (2020)
There remain a number of uncertainties globally about the risks posed to women who are infected with SARS-CoV-2 during pregnancy. Furthermore, our understanding of the spread of COVID-19 in Sub-Saharan Africa is limited, owing to low testing rates in many parts of the continent. PeriCOVID Africa, in conjunction with the WHO/HRP Alliance, plans to address these knowledge gaps by harnessing research infrastructures in place in five sub-Saharan African countries in order to screen more than 50,000 pregnant women and their infants for SARS-CoV-2, while monitoring pregnancy and neonatal outcomes. We anticipate that the results of this study will provide much needed information about the risks that SARS-CoV-2 poses to pregnant women and their babies, as well as establishing potential routes of mother-to-child transmission.
Keyphrases
- sars cov
- pregnant women
- pregnancy outcomes
- respiratory syndrome coronavirus
- human health
- healthcare
- mental health
- coronavirus disease
- high throughput
- risk assessment
- preterm birth
- gestational age
- health information
- big data
- deep learning
- metabolic syndrome
- machine learning
- skeletal muscle
- health insurance
- cord blood
- glycemic control